Ambitious ‘cloud brightening’ experiment launched to restore Great Barrier Reef
Results from the trial were “really, really encouraging”, the project’s lead scientist Daniel Harrison from Southern Cross University said.
Results from the trial were “really, really encouraging”, the project’s lead scientist Daniel Harrison from Southern Cross University said.
Mental health conditions such as obsessive compulsive disorder (OCD) could be treated in a new way using drugs that target the immune system instead of the central nervous system, suggests exciting new research.
The new treatment is rapidly approaching human trials and hopes to have an FDA-approved treatment out the other end of the pipeline in 2-3 years.
Spoiler: True happiness comes not from setting ourselves above and apart from others, but from joining and serving our communities.
While the six-junction III-V technology underlying these new cells is likely too costly at this time to be put to use in everyday rooftop applications, the new cell has great potential for application in concentrated solar panel arrays.
In several of the patients the virus cleared up entirely, leading the authors to conclude that plasma “can serve as a promising rescue option” for severe COVID-19 cases.
“There’s never been a therapy for treatment-resistant depression that’s broken 55% remission rates in open-label testing,” the team says.
Researchers say the test can not only tell whether someone has cancer, but can also shed light on the type of cancer they have.
The new point-of-care test, having just received an emergency-use authorization by the U.S. Food and Drug Administration (FDA) begins shipping today, April 1.
Kinsa Health, a company that produces internet-connected thermometers, first created a national map of fever levels in the U.S. on March 22 and was able to spot the trend within a day.